Eqis Capital Management, Inc. Emergent Bio Solutions Inc. Transaction History

Eqis Capital Management, Inc.

$1.19 Billion
Q1 2024

A detailed history of Eqis Capital Management, Inc. transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Eqis Capital Management, Inc. holds 15,811 shares of EBS stock, worth $125,381. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,811

Holding current value

$125,381

% of portfolio

0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$1.5 - $3.41 $23,716 - $53,915	15,811 New	15,811 $40,000
Q2 2022 Aug 08, 2022	SELL	$27.42 - $43.63 $144,256 - $229,537	-5,261 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$36.48 - $52.22 $11,637 - $16,658	-319 Reduced 5.72%	5,261 $216,000
Q4 2021 Feb 14, 2022	SELL	$33.11 - $55.01 $5,496 - $9,131	-166 Reduced 2.89%	5,580 $243,000
Q3 2021 Nov 12, 2021	SELL	$50.07 - $66.05 $36,100 - $47,622	-721 Reduced 11.15%	5,746 $288,000

Q2 2021 Aug 12, 2021	SELL	$56.61 - $80.46 $165,301 - $234,943	-2,920 Reduced 31.11%	6,467 $407,000
Q1 2021 May 14, 2021	SELL	$86.23 - $125.19 $470,902 - $683,662	-5,461 Reduced 36.78%	9,387 $872,000
Q4 2020 Feb 11, 2021	SELL	$79.17 - $111.47 $878,153 - $1.24 Million	-11,092 Reduced 42.76%	14,848 $1.33 Million
Q3 2020 Nov 10, 2020	SELL	$81.91 - $134.94 $247,286 - $407,383	-3,019 Reduced 10.43%	25,940 $2.68 Million
Q2 2020 Aug 10, 2020	SELL	$54.33 - $89.52 $200,912 - $331,044	-3,698 Reduced 11.32%	28,959 $2.29 Million
Q1 2020 May 12, 2020	BUY	$49.34 - $68.76 $66,362 - $92,482	1,345 Added 4.3%	32,657 $2 Million
Q4 2019 Jan 24, 2020	SELL	$51.21 - $59.06 $176,725 - $203,816	-3,451 Reduced 9.93%	31,312 $1.69 Million
Q3 2019 Nov 05, 2019	SELL	$40.6 - $57.2 $219,199 - $308,822	-5,399 Reduced 13.44%	34,763 $1.82 Million
Q2 2019 Jul 18, 2019	SELL	$39.92 - $53.86 $126,905 - $171,220	-3,179 Reduced 7.33%	40,162 $1.94 Million
Q1 2019 Apr 18, 2019	SELL	$48.23 - $66.16 $173,483 - $237,977	-3,597 Reduced 7.66%	43,341 $2.19 Million
Q4 2018 Jan 25, 2019	SELL	$55.63 - $73.24 $713,732 - $939,669	-12,830 Reduced 21.47%	46,938 $2.78 Million
Q3 2018 Oct 17, 2018	BUY	$52.05 - $66.51 $237,139 - $303,019	4,556 Added 8.25%	59,768 $3.65 Million
Q2 2018 Jul 27, 2018	BUY	$48.33 - $55.64 $222,366 - $255,999	4,601 Added 9.09%	55,212 $2.79 Million
Q1 2018 Apr 06, 2018	BUY	$44.44 - $54.39 $478,885 - $586,106	10,776 Added 27.05%	50,611 $2.67 Million
Q4 2017 Jan 25, 2018	BUY	$37.77 - $47.75 $109,306 - $138,188	2,894 Added 7.83%	39,835 $1.85 Million
Q3 2017 Oct 03, 2017	BUY	$34.14 - $40.45 $1.26 Million - $1.49 Million	36,941	36,941 $1.49 Million

Others Institutions Holding EBS

# of Institutions

137

Shares Held

35.6M

Call Options Held

78.7K

Put Options Held

75.1K

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $395M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Eqis Capital Management, Inc. with notifications on news.

Account

Eqis Capital Management, Inc. Emergent Bio Solutions Inc. Transaction History